184 related articles for article (PubMed ID: 31518071)
1. Current trend of worsening prognosis of prostate small cell carcinoma: A population-based study.
Wang J; Liu X; Wang Y; Ren G
Cancer Med; 2019 Nov; 8(15):6799-6806. PubMed ID: 31518071
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological characteristics and survival outcomes in neuroendocrine prostate cancer: A population-based study.
Zhu J; Liang X; Wu D; Chen S; Yang B; Mao W; Shen D
Medicine (Baltimore); 2021 Apr; 100(15):e25237. PubMed ID: 33847621
[TBL] [Abstract][Full Text] [Related]
3. Contemporary Incidence and Cancer Control Outcomes of Primary Neuroendocrine Prostate Cancer: A SEER Database Analysis.
Zaffuto E; Pompe R; Zanaty M; Bondarenko HD; Leyh-Bannurah SR; Moschini M; Dell'Oglio P; Gandaglia G; Fossati N; Stabile A; Zorn KC; Montorsi F; Briganti A; Karakiewicz PI
Clin Genitourin Cancer; 2017 Oct; 15(5):e793-e800. PubMed ID: 28506524
[TBL] [Abstract][Full Text] [Related]
4. A Limited-Versus-Extensive Staging Strategy for Small Cell Prostate Cancer.
Syed S; Basourakos SP; Ali FS; Garcia JL; Zurita-Saavedra A; Gong Z
Am J Clin Oncol; 2020 Feb; 43(2):87-93. PubMed ID: 31764016
[TBL] [Abstract][Full Text] [Related]
5. Survival of patients with small cell carcinoma of the prostate during 1973-2003: a population-based study.
Deorah S; Rao MB; Raman R; Gaitonde K; Donovan JF
BJU Int; 2012 Mar; 109(6):824-30. PubMed ID: 21883857
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study.
Cattrini C; Cerbone L; Rubagotti A; Zinoli L; Latocca MM; Messina C; Zanardi E; Boccardo F
Clin Genitourin Cancer; 2019 Aug; 17(4):e724-e732. PubMed ID: 31160193
[TBL] [Abstract][Full Text] [Related]
7. Incidence, Clinical Characteristics, and Survival of Collecting Duct Carcinoma of the Kidney: A Population-Based Study.
Tang C; Zhou Y; Ge S; Yi X; Lv H; Zhou W
Front Oncol; 2021; 11():727222. PubMed ID: 34595117
[TBL] [Abstract][Full Text] [Related]
8. The prognosis of different distant metastases pattern in prostate cancer: A population based retrospective study.
Shou J; Zhang Q; Wang S; Zhang D
Prostate; 2018 May; 78(7):491-497. PubMed ID: 29436722
[TBL] [Abstract][Full Text] [Related]
9. The contemporary trend in worsening prognosis of pancreatic acinar cell carcinoma: A population-based study.
Duorui N; Shi B; Zhang T; Chen C; Fang C; Yue Z; Wu P; Wu Z; Huang X; Li M
PLoS One; 2020; 15(12):e0243164. PubMed ID: 33332471
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
11. The local treatment modalities in FIGO stage I-II small-cell carcinoma of the cervix are determined by disease stage and lymph node status.
Zhou J; Yang HY; Wu SG; He ZY; Lin HX; Sun JY; Li Q; Guo ZW
Cancer Med; 2016 Jun; 5(6):1108-15. PubMed ID: 26990881
[TBL] [Abstract][Full Text] [Related]
12. Survival analysis of patients with subglottic squamous cell carcinoma based on the SEER database.
Yang F; He L; Rao Y; Feng Y; Wang J
Braz J Otorhinolaryngol; 2022; 88 Suppl 4(Suppl 4):S70-S80. PubMed ID: 34716102
[TBL] [Abstract][Full Text] [Related]
13. Risk of prostate carcinoma death in patients with lymph node metastasis.
Cheng L; Zincke H; Blute ML; Bergstralh EJ; Scherer B; Bostwick DG
Cancer; 2001 Jan; 91(1):66-73. PubMed ID: 11148561
[TBL] [Abstract][Full Text] [Related]
14. A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends.
Koay EJ; Teh BS; Paulino AC; Butler EB
Cancer; 2011 Dec; 117(23):5325-33. PubMed ID: 21567387
[TBL] [Abstract][Full Text] [Related]
15. Prognostic values of clinicopathological characteristics and survival outcomes in prostate infiltrating ductal carcinoma: a population-based study.
Wu YP; Chen SH; Wang ST; Li XD; Cai H; Lin YZ; Xue XY; Wei Y; Zheng QS; Xu N
Oncotarget; 2017 Apr; 8(17):29048-29055. PubMed ID: 28423709
[TBL] [Abstract][Full Text] [Related]
16. Patterns of care and outcomes in small cell carcinoma of the prostate: A national cancer database analysis.
Metzger AL; Abel S; Wegner RE; Fuhrer R; Mao S; Miller R; Beriwal S; Horne ZD
Prostate; 2019 Sep; 79(12):1457-1461. PubMed ID: 31294484
[TBL] [Abstract][Full Text] [Related]
17. Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program.
Cetin K; Beebe-Dimmer JL; Fryzek JP; Markus R; Carducci MA
Urology; 2010 Jun; 75(6):1396-404. PubMed ID: 19969335
[TBL] [Abstract][Full Text] [Related]
18. Comparison of outcomes between rectal squamous cell carcinoma and adenocarcinoma.
Chiu MS; Verma V; Bennion NR; Bhirud AR; Li J; Charlton ME; Are C; Lin C
Cancer Med; 2016 Dec; 5(12):3394-3402. PubMed ID: 27781400
[TBL] [Abstract][Full Text] [Related]
19. Risk of lymph node metastases in pathological gleason score≤6 prostate adenocarcinoma: Analysis of institutional and population-based databases.
Wenger H; Weiner AB; Razmaria A; Paner GP; Eggener SE
Urol Oncol; 2017 Jan; 35(1):31.e1-31.e6. PubMed ID: 27692833
[TBL] [Abstract][Full Text] [Related]
20. Regional Lymph Node Involvement Is Associated With Poorer Survivorship in Patients With Chondrosarcoma: A SEER Analysis.
Wan L; Tu C; Li S; Li Z
Clin Orthop Relat Res; 2019 Nov; 477(11):2508-2518. PubMed ID: 31283732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
